Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review
Related Experiment Video
Updated: Dec 5, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Emir Yonas1, Idrus Alwi2, Raymond Pranata3
1Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia.
Insights
Patients with heart failure (HF) face a significantly higher risk of severe outcomes, including hospitalization, poor prognosis, and death from COVID-19. This systematic review confirms HF as a critical comorbidity impacting COVID-19 mortality.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Comorbidities like hypertension and diabetes increase COVID-19 severity and mortality risk.
- Heart failure (HF) is a significant comorbidity requiring investigation for its impact on COVID-19 outcomes.
Purpose of the Study:
- To systematically review and meta-analyze the association between pre-existing heart failure (HF) and adverse outcomes in COVID-19 patients.
- To quantify the risk of mortality and poor prognosis in COVID-19 patients with heart failure.
Main Methods:
- Systematic literature search of major databases (PubMed, SCOPUS, etc.) using keywords 'Heart failure' and 'COVID-19'.
- Inclusion of 18 studies with 21,640 patients for qualitative synthesis and meta-analysis.
- Analysis of outcomes including hospitalization, severe COVID-19, ICU admission, ventilator use, and mortality.
Main Results:
- Heart failure (HF) was significantly associated with increased hospitalization (HR 2.37) and poor outcomes (OR 2.86) in COVID-19 patients.
- Patients with pre-existing HF exhibited a substantially higher mortality risk (OR 3.46) compared to those without HF.
- High heterogeneity was noted across the analyzed studies for all outcomes.
Conclusions:
- Heart failure is a critical risk factor for adverse outcomes in COVID-19, including increased hospitalization, poor prognosis, and higher mortality.
- A significant disparity in mortality rates was observed, with COVID-19 patients who have heart failure experiencing considerably worse survival.
- The findings underscore the importance of managing heart failure in patients diagnosed with COVID-19.
Background:
Several comorbidities have been associated with an increased risk of severity and mortality in coronavirus disease 2019 (COVID-19), including hypertension, diabetes, cerebrovascular disease, chronic kidney disease, and chronic obstructive pulmonary disease.
Purpose:
In this systematic review and meta-analysis, we attempted to investigate the association between heart failure (HF) and poor outcome in patients with COVID-19.
Methods:
We performed a systematic literature search from PubMed, EuropePMC, SCOPUS, Cochrane Central Database, and medRxiv with the search terms, "Heart failure" and "COVID-19". The outcome of interest was mortality and poor prognosis (defined by incidence of severe COVID-19 infection, admission to ICU, and use of ventilator) in patients with preexisting heart failure with coronavirus disease.
Results:
We identified 204 potential articles from our search, and 22 duplicates were removed. After screening of the titles and abstracts of the remaining 182 articles we identified 92 potentially relevant articles. We excluded 74 studies due to the following reasons: four studies were systematic reviews, two studies were meta-analyses, three articles were literature reviews, and 65 articles did not report on the outcome of interest. Finally, we included the remaining 18 studies in our qualitative synthesis and meta-analysis. There were 21,640 patients from 18 studies. HF was associated with hospitalization in COVID19 HR was 2.37 [1.48, 3.79; p < 0.001], high heterogeneity [I2, 82%; p < 0.001]. HF was associated with a poor outcome demonstrated by an OR of 2.86 [2.07; 3.95; p < 0.001] high heterogeneity [I2, 80%; p < 0.001]. Patient with preexisting HF was associated with higher mortality OR of 3.46 [2.52, 4.75; p < 0.001] moderately high heterogeneity [I2, 77%; p < 0.001].
Conclusion:
Patients with heart failure are at increased risk for hospitalization, poor outcome, and death from COVID-19. A significant difference in mortality between patients with and without heart failure was observed, patients with heart failure having a higher mortality.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System